One-Year Outcomes of Faricimab Treatment for Aflibercept-Resistant Neovascular Age-Related Macular Degeneration

PURPOSE: To assess the 12-month outcomes of intravitreal faricimab (IVF) in treatment-resistant neovascular age-related macular degeneration (nAMD) subjects recalcitrant to intravitreal aflibercept (IVA). METHODS: This study was conducted as a retrospective interventional case series of nAMD patient...

Descripción completa

Detalles Bibliográficos
Autor principal: Rush, Ryan B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404054/
https://www.ncbi.nlm.nih.gov/pubmed/37547172
http://dx.doi.org/10.2147/OPTH.S424315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404054/
https://www.ncbi.nlm.nih.gov/pubmed/37547172
http://dx.doi.org/10.2147/OPTH.S424315

Ejemplares similares